Literature DB >> 5055210

The complement system of man. 3.

S Ruddy, I Gigli, K F Austen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5055210     DOI: 10.1056/NEJM197209212871206

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  13 in total

1.  Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.

Authors:  L H Perrin; P H Lambert; P A Miescher
Journal:  J Clin Invest       Date:  1975-07       Impact factor: 14.808

Review 2.  Urticaria--current concepts.

Authors:  A Taaffe
Journal:  Postgrad Med J       Date:  1977-12       Impact factor: 2.401

3.  Deficiency of the second component of complement associated with anaphylactoid purpura and presence of mycoplasma in the serum.

Authors:  M Sussman; J H Jones; J D Almeida; P J Lachmann
Journal:  Clin Exp Immunol       Date:  1973-08       Impact factor: 4.330

4.  Serum complement and immunoconglutinin in malnutrition.

Authors:  R K Chandra
Journal:  Arch Dis Child       Date:  1975-03       Impact factor: 3.791

Review 5.  Modulation of human eosinophil polymorphonuclear leukocyte migration and function.

Authors:  E J Goetzl
Journal:  Am J Pathol       Date:  1976-11       Impact factor: 4.307

6.  Partial H (beta 1H) deficiency and glomerulonephritis in two families.

Authors:  R J Wyatt; B A Julian; A Weinstein; N F Rothfield; R H McLean
Journal:  J Clin Immunol       Date:  1982-04       Impact factor: 8.317

7.  Properdin levels in systemic lupus erythematosus and membranoproleferative glomerulonephritis.

Authors:  L H Perrin; P H Lambert; P A Miescher
Journal:  Clin Exp Immunol       Date:  1974-04       Impact factor: 4.330

8.  Levels of total haemolytic complement activity in paired dairy cow-newborn calf sera.

Authors:  H W Renshaw; W P Eckblad; P D Tassinari; D O Everson
Journal:  Immunology       Date:  1978-05       Impact factor: 7.397

9.  Preferential activation and depletion of the alternative complement pathway by burn injury.

Authors:  J A Gelfand; M Donelan; J F Burke
Journal:  Ann Surg       Date:  1983-07       Impact factor: 12.969

Review 10.  Clinical conditions associated with defective polymorphonuclear leukocyte chemotaxis.

Authors:  P G Quie; K L Cates
Journal:  Am J Pathol       Date:  1977-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.